Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Trichoscopy is useful for diagnosing hair and scalp disorders in people with darker skin.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Mice with a mutated Dsg3 gene showed severe symptoms but not the typical blistering of pemphigus vulgaris.

Syphilitic alopecia is a rare hair loss condition in secondary syphilis that looks similar to another condition but can be diagnosed with specific tests and responds to antibiotics.

Hypothyroidism may cause certain types of hair loss.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Scanning electron microscopy revealed four distinct hair root shapes in alopecia areata, suggesting a less invasive diagnostic method.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

Hair transplantation can successfully treat stubborn alopecia areata.